Kura Oncology, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue18.3M17.3M20.8M15.3M14.1M53.9M00
Cost of Goods Sold617K03.2M0000202K
Gross Profit17.6M17.3M17.5M15.3M14.1M53.9M0-202K
R&D Expenses65.3M64.4M67.9M62.8M56.0M52.3M41.7M39.7M
Operating Expenses96.5M103.6M97.5M88.0M78.8M76.3M59.9M56.2M
Operating Income-78.8M-86.3M-80.0M-72.7M-64.7M-22.5M-59.9M-56.4M
Other Income / Gains5.5M5.3M5.9M6.5M7.5M5.3M5.5M5.6M
Net Income-73.3M-81.0M-74.1M-66.1M-57.4M-19.2M-54.4M-50.8M
EPS (Diluted)-0.83-0.92-0.85-0.75-0.66-0.22-0.63-0.59
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.9661.000.8451.001.001.0000
General And Administrative Expenses039.1M32.8M25.2M22.8M24.1M18.2M16.7M
Selling And Marketing Expenses0000000-202K
Selling General And Administrative Expenses31.2M39.1M32.8M25.2M22.8M24.1M18.2M16.5M
Other Expenses057K-3.2M00000
Cost And Expenses97.1M103.6M100.7M88.0M78.8M76.3M59.9M56.4M
Interest Income5.8M5.7M6.3M6.9M7.9M5.7M5.9M6.0M
Interest Expense336K346K393K391K382K403K412K406K
Depreciation And Amortization355K403K164K224K241K204K208K202K
Ebitda-72.6M-80.2M-74.0M-65.5M-57.3M-16.6M-53.8M-50.2M
Ebitdaratio-3.977-4.625-3.564-4.285-4.065-0.30800
Operating Income Ratio-4.315-4.976-3.855-4.753-4.586-0.41700
Income Before Tax-73.3M-80.9M-74.1M-66.1M-57.2M-17.2M-54.4M-50.8M
Income Before Tax Ratio-4.015-4.668-3.572-4.325-4.055-0.31900
Income Tax Expense8K71K00226K2.0M00
Net Income Ratio-4.015-4.672-3.572-4.325-4.071-0.35700
Epsdiluted-0.83-0.92-0.85-0.75-0.66-0.22-0.63-0.59
Weighted Average Shs Out88.6M88.0M87.6M87.6M87.4M87.1M87.0M86.6M
Weighted Average Shs Out Dil88.6M88.0M87.6M87.6M87.4M87.1M87.0M86.6M